PH30677A - Acylsulfoamido-and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides processes for their preparation and their use as medicaments - Google Patents

Acylsulfoamido-and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides processes for their preparation and their use as medicaments

Info

Publication number
PH30677A
PH30677A PH46989A PH46989A PH30677A PH 30677 A PH30677 A PH 30677A PH 46989 A PH46989 A PH 46989A PH 46989 A PH46989 A PH 46989A PH 30677 A PH30677 A PH 30677A
Authority
PH
Philippines
Prior art keywords
pyridine
oxides
carboxylic acid
acid esters
medicaments
Prior art date
Application number
PH46989A
Other languages
English (en)
Inventor
Klaus Weidmann
Martin Bickel
Volkmar Gunzer-Pukall
Karl-Heinz Baringhaus
Original Assignee
Hoechst Aktien Ges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktien Ges filed Critical Hoechst Aktien Ges
Publication of PH30677A publication Critical patent/PH30677A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH46989A 1992-10-02 1993-09-30 Acylsulfoamido-and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides processes for their preparation and their use as medicaments PH30677A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233124A DE4233124A1 (de) 1992-10-02 1992-10-02 Acylsulfonamido- und Sulfonamidopyridin-2-carbonsäureester sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PH30677A true PH30677A (en) 1997-09-16

Family

ID=6469456

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46989A PH30677A (en) 1992-10-02 1993-09-30 Acylsulfoamido-and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides processes for their preparation and their use as medicaments

Country Status (25)

Country Link
US (1) US5428046A (fi)
EP (1) EP0590520B1 (fi)
JP (1) JPH06211795A (fi)
KR (1) KR940009156A (fi)
CN (1) CN1089603A (fi)
AT (1) ATE139227T1 (fi)
AU (1) AU662448B2 (fi)
CA (1) CA2107514A1 (fi)
CZ (1) CZ283869B6 (fi)
DE (2) DE4233124A1 (fi)
DK (1) DK0590520T3 (fi)
ES (1) ES2090806T3 (fi)
FI (1) FI103881B (fi)
GR (1) GR3020230T3 (fi)
HK (1) HK1006713A1 (fi)
HU (1) HUT67292A (fi)
IL (1) IL107155A (fi)
MY (1) MY110277A (fi)
NO (1) NO180085C (fi)
NZ (1) NZ248819A (fi)
PH (1) PH30677A (fi)
PL (1) PL176772B1 (fi)
RU (1) RU2117660C1 (fi)
TW (1) TW258733B (fi)
ZA (1) ZA937298B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
DE19742951A1 (de) * 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
DE4031000A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Also Published As

Publication number Publication date
NO933521D0 (no) 1993-10-01
NZ248819A (en) 1996-02-27
ZA937298B (en) 1994-04-25
US5428046A (en) 1995-06-27
FI934303A (fi) 1994-04-03
TW258733B (fi) 1995-10-01
IL107155A (en) 1999-09-22
MY110277A (en) 1998-03-31
ATE139227T1 (de) 1996-06-15
NO933521L (no) 1994-04-05
FI103881B1 (fi) 1999-10-15
AU4872693A (en) 1994-04-14
IL107155A0 (en) 1993-12-28
DK0590520T3 (da) 1996-10-14
AU662448B2 (en) 1995-08-31
CZ283869B6 (cs) 1998-06-17
CZ204493A3 (en) 1994-05-18
KR940009156A (ko) 1994-05-20
DE59302898D1 (de) 1996-07-18
JPH06211795A (ja) 1994-08-02
ES2090806T3 (es) 1996-10-16
RU2117660C1 (ru) 1998-08-20
FI934303A0 (fi) 1993-09-30
HUT67292A (en) 1995-03-28
CA2107514A1 (en) 1994-04-03
NO180085C (no) 1997-02-12
PL176772B1 (pl) 1999-07-30
NO180085B (no) 1996-11-04
FI103881B (fi) 1999-10-15
HK1006713A1 (en) 1999-03-12
GR3020230T3 (en) 1996-09-30
EP0590520B1 (de) 1996-06-12
EP0590520A1 (de) 1994-04-06
HU9302778D0 (en) 1993-12-28
PL300561A1 (en) 1994-04-05
CN1089603A (zh) 1994-07-20
DE4233124A1 (de) 1994-04-07

Similar Documents

Publication Publication Date Title
HUT69685A (en) Sulphonamido and sulphonamido-carbonyl-pyridine-2-carboxylic acid amides, their n-oxides, method for producing them and pharmaceutical preparatives containing them
IL100328A0 (en) Dihydro isoquinoline derivatives,their production and pharmaceutical compositions containing them
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
AU7720891A (en) Novel intermediates for the preparation of novel 5(and/or 6) substituted 2(2-imidazolin-2-yl)nicotinic acids, esters and salts, useful as herbicidal agents
AU8217787A (en) Process for the preparation of quinoline carboxylic acids
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
ZA937298B (en) Acyisulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides processes for their preparation and their use as medicaments
AU638437B2 (en) Substituted azetidinylpyridonecarboxylic acid derivatives, their preparation and their application as medicinal products
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
GR3019381T3 (en) 3-Anilino-2-hydroxycarbonyl-4-thiophen-acetic acids
GR3022259T3 (en) Tetrahydro-4-phenylimino-3-thiophen-acetic acids
ZA928165B (en) Pharmaceuticals "pyridine-3-carboxylic acid esters or amides useful as 5-ht3antagonists".
GR3006610T3 (fi)